ELXMF Stock - Nova Eye Medical Limited
Unlock GoAI Insights for ELXMF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $29.27M | $23.32M | $17.02M | $13.38M | $13.39M |
| Gross Profit | $18.89M | $20.19M | $842,000 | $-765,000 | $1.77M |
| Gross Margin | 64.5% | 86.6% | 4.9% | -5.7% | 13.2% |
| Operating Income | $-4,504,000 | $-8,968,000 | $-11,849,000 | $-6,586,000 | $-4,965,000 |
| Net Income | $-9,059,000 | $-8,790,000 | $-15,293,000 | $-7,496,000 | $-4,356,000 |
| Net Margin | -31.0% | -37.7% | -89.8% | -56.0% | -32.5% |
| EPS | $-0.04 | $-0.04 | $-0.10 | $-0.05 | $-0.03 |
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.
Visit WebsiteEarnings History & Surprises
ELXMFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 24, 2026 | — | — | — | — |
Q3 2025 | Aug 27, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 21, 2025 | $-0.00 | $-0.01 | -249.5% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | — | — | — | — |
Q3 2024 | Aug 25, 2024 | — | $-0.01 | — | — |
Q1 2024 | Feb 23, 2024 | — | $-0.02 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.03 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.03 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | $-0.01 | $-0.02 | -293.4% | ✗ MISS |
Q4 2019 | Dec 31, 2019 | $-0.01 | $-0.01 | -21.5% | ✗ MISS |
Q2 2019 | Jun 30, 2019 | — | $-0.01 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.02 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.01 | — | — |
Q1 2018 | Feb 26, 2018 | — | $-0.02 | — | — |
Q3 2017 | Aug 25, 2017 | — | $-0.01 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.01 | — | — |
Latest News
Frequently Asked Questions about ELXMF
What is ELXMF's current stock price?
What is the analyst price target for ELXMF?
What sector is Nova Eye Medical Limited in?
What is ELXMF's market cap?
Does ELXMF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ELXMF for comparison